Sign inJoin waitlistJoin the waitlist

Matthew B. Rettig

Medical Director, Prostate Cancer Program · Institute of Urologic Oncology at UCLA

Credentials: · · ·

History

Prostate Cancer Program · Institute of Urologic Oncology at UCLA
Present

UCLA School of Medicine
Until 1996
University of Washington School of Medicine
Until 1993
LAC + USC Medical Center
Until 1991
Duke University School of Medicine
1990

Research

Clinical and Genomic Characterization of Treatment-Emergent Small-Cell Neuroendocrine Prostate Cancer: A Multi-institutional Prospective Study
Journal of Clinical Oncology · 2018 · 673 citations
Assessment of 68Ga-PSMA-11 PET Accuracy in Localizing Recurrent Prostate Cancer: A Prospective Single-Arm Clinical Trial
JAMA Oncology · 2019 · 672 citations
Genomic Hallmarks and Structural Variation in Metastatic Prostate Cancer
Cell · 2018 · 551 citations

Robert Reiter
74 papers
Nicholas Nickols
69 papers · 1 as a resident
Amar Kishan
62 papers · 3 as a resident
Michael Steinberg
48 papers
Jeremie Calais
46 papers
Daniel Spratt
35 papers
Felix Feng
35 papers
Luca Valle
33 papers · 9 as a resident
Johannes Czernin
32 papers
Martin Ma
23 papers · 14 as a resident
Eric Small
22 papers
Jiaoti Huang
22 papers · 2 as a resident

Grants

Phase II Trial of Targeted Radiation with No Castration for Mcrpc (POTENT-C)
Department of Veterans Affairs · I01
PI · Va Greater Los Angeles Healthcare System
2024–2028
Predicting Metastatic Progression of High Risk Localized Prostate Cancer
Department of Veterans Affairs · I01
Contact PI · Va Greater Los Angeles Healthcare System
2023–2027
A Phase 2 Study of a Checkpoint Inhibitor in Men with Progressive Metastatic Castrate Resistant Prostate Cancer Characterized by a Mismatch Repair Deficiency or Biallelic CDK12 Inactivation
Department of Veterans Affairs · I01
Contact PI · Va Greater Los Angeles Healthcare System
2020–2027
UCLA SPORE in Prostate Cancer
National Cancer Institute · P50
Project lead · $1.4M · University of California Los Angeles
2002–2025

Clinical trials

Role of Race in Nutritional Approach in Men on ADT
Principal investigator · Recruiting
University of California, Los Angeles
2024–2027
Hormonal Intervention for the Treatment in Veterans With COVID-19 Requiring Hospitalization
Principal investigator · Completed · Phase 2
VA Office of Research and Development
2020–2021
A Study of CHeckpoint Inhibitors in Men With prOgressive Metastatic Castrate Resistant Prostate Cancer Characterized by a Mismatch Repair Deficiency or Biallelic CDK12 Inactivation
Principal investigator · Active not recruiting · Phase 2
VA Office of Research and Development
2020–2026
Image-Guided Biopsies in Identifying Mechanisms of Resistance in Participants With Metastatic Castration Resistant Prostate Cancer Undergoing Radioligand Therapy
Principal investigator · Withdrawn
Jonsson Comprehensive Cancer Center
2018–2022